Wang Tim T, Nadella Srighana, Lee Cameron C, Hersh Elliot V, Tannyhill R John, Panchal Neeraj
Resident, Oral & Maxillofacial Surgery, Massachusetts General Hospital and Clinical Fellow, Harvard School of Dental Medicine, Boston, MA.
DMD Candidate, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA.
J Oral Maxillofac Surg. 2022 Apr;80(4):614-619. doi: 10.1016/j.joms.2021.10.018. Epub 2021 Nov 5.
This study compared opioid prescription patterns among oral and maxillofacial surgeons (OMSs) treating Medicare beneficiaries in urban and rural settings, in an effort to identify avenues to further promote responsible opioid prescribing in a patient demographic vulnerable to opioid diversion.
This study used Medicare Provider Utilization and Payment Data from 2014 to 2018, focusing on providers labeled as an OMS. Rural-urban commuting area codes were used to categorize each OMS as urban or rural. The demographic variables included total number of OMSs, provider gender, beneficiaries per provider, beneficiaries' age, and beneficiary hierarchal condition category (proxy for clinical complexity). The outcome variables included opioid prescribing rate, opioid claims per provider, opioid claims per beneficiary, and number of days' supply of opioids per claim. Descriptive statistics, χ tests, 2-tailed t tests, and Wilcoxon rank-sum tests were used as appropriate.
Across all years, the data consisted of mostly urban and male OMSs. The mean number of Medicare beneficiaries prescribed opioids per OMS varied widely, and the mean age of beneficiaries was 70.4 ± 4.4 and 69.9 ± 4.1 years for urban and rural OMSs, respectively. Mean opioid claims per provider were higher among rural OMSs, with large standard deviations among both rural and urban OMSs. However, there were no significant differences in the opioid prescribing rate or in the mean opioid claims per beneficiary in all 5 years included in the study. There were also no clinically significant differences between urban and rural OMSs in the number of days' supply per claim (between 3 and 4 days in all periods). However, in each year, there was a significantly higher proportion of urban OMSs who prescribed more than 7 days' supply per claim.
Opioid prescription practices were generally similar between rural and urban OMSs treating Medicare beneficiaries. The small subset of longer-term opioid prescribers, which were more prevalent in urban areas, warrants further investigation.
本研究比较了在城市和农村地区治疗医疗保险受益人的口腔颌面外科医生(OMS)的阿片类药物处方模式,以确定在易发生阿片类药物转移的患者群体中进一步促进负责任的阿片类药物处方的途径。
本研究使用了2014年至2018年的医疗保险提供者利用和支付数据,重点关注标记为OMS的提供者。城乡通勤区号用于将每个OMS分类为城市或农村。人口统计学变量包括OMS总数、提供者性别、每个提供者的受益人数量、受益人的年龄以及受益人分层病情类别(临床复杂性的代理指标)。结果变量包括阿片类药物处方率、每个提供者的阿片类药物索赔、每个受益人的阿片类药物索赔以及每次索赔的阿片类药物供应天数。根据需要使用描述性统计、χ检验、双尾t检验和Wilcoxon秩和检验。
在所有年份中,数据主要包括城市和男性OMS。每个OMS开具阿片类药物处方的医疗保险受益人平均数量差异很大,城市和农村OMS的受益人平均年龄分别为70.4±4.4岁和69.9±4.1岁。农村OMS中每个提供者的平均阿片类药物索赔较高,农村和城市OMS中的标准差都很大。然而,在研究涵盖的所有5年中,阿片类药物处方率或每个受益人的平均阿片类药物索赔没有显著差异。城市和农村OMS在每次索赔的供应天数方面也没有临床显著差异(所有时期均在3至4天之间)。然而,在每年中,开具每次索赔超过7天供应量的城市OMS比例明显更高。
治疗医疗保险受益人的农村和城市OMS的阿片类药物处方做法总体相似。城市中更普遍的长期阿片类药物处方者这一小部分人群值得进一步调查。